Albuterol Sulfate Hfa Aerosol, Metered
Product Images NDC 50090-4137

15 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Albuterol Sulfate Hfa (NDC 50090-4137). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Albuterolhfa Spl Graphic 01)

Chemical Structure (Albuterolhfa Spl Graphic 01)
Chemical structure of albuterol sulfate. The diagram shows the molecular arrangement including hydroxyl groups, aromatic ring, and side chains, along with two sulfate (H2SO4) units, consistent with the sulfate salt form of albuterol.*
FDA Label Image

Fev1 As Percent Change From Predose In A Large, 12-week Clinical Trial, Day 1 (Albuterolhfa Spl Graphic 02)

Fev1 As Percent Change From Predose In A Large, 12-week Clinical Trial, Day 1 (Albuterolhfa Spl Graphic 02)
A line chart showing mean percent change from baseline over 6 hours comparing three treatments: CFC 11/12-propelled albuterol, albuterol sulfate HFA, and an HFA-134a placebo inhaler. The y-axis ranges from -4 to 40 percent change, and the x-axis shows time in hours from 0 to 6. Data points illustrate higher initial percent change for active treatments versus placebo, with gradual decline over time.*
FDA Label Image

Fev1 As Percent Change From Predose In A Large, 12-week Clinical Trial, Week 12 (Albuterolhfa Spl Graphic 03)

Fev1 As Percent Change From Predose In A Large, 12-week Clinical Trial, Week 12 (Albuterolhfa Spl Graphic 03)
A line graph depicting mean percentage change from baseline over 6 hours following inhalation of albuterol formulations. It compares CFC 11/12-propelled albuterol (2 inhalations, 4 times daily), albuterol sulfate HFA (2 inhalations, 4 times daily), and HFA-134a placebo inhaler (2 inhalations, 4 times daily). The graph shows higher and similar response trends for both albuterol forms compared to the placebo, which remains near baseline over time.*
FDA Label Image

Figure A (Albuterolhfa Spl Graphic 04)

Figure A (Albuterolhfa Spl Graphic 04)
Illustration showing the parts of an albuterol sulfate HFA metered-dose inhaler, including the metal canister, plastic actuator, mouthpiece, dose counter, and removable cap.*
FDA Label Image

Figure B (Albuterolhfa Spl Graphic 05)

Figure B (Albuterolhfa Spl Graphic 05)
An instructional illustration depicting a person removing the cap from an albuterol sulfate HFA metered-dose inhaler. The image shows one hand holding the inhaler and the other hand pulling the mouthpiece cap off, indicated by an arrow.*
FDA Label Image

Figure C (Albuterolhfa Spl Graphic 06)

Figure C (Albuterolhfa Spl Graphic 06)
An instructional illustration showing proper use of an albuterol sulfate HFA aerosol inhaler. A hand is pressing down on the inhaler spray canister while the mouthpiece is placed near the user's mouth to inhale the medication. The image depicts the action to spray the inhaler.*
FDA Label Image

Figure D (Albuterolhfa Spl Graphic 07)

Figure D (Albuterolhfa Spl Graphic 07)
An instructional line drawing showing a hand holding an aerosol inhaler with a dosage counter displaying the number 200. The image suggests proper grip or use of the metered-dose inhaler, consistent with albuterol sulfate HFA inhaler devices.*
FDA Label Image

Figure E (Albuterolhfa Spl Graphic 08)

Figure E (Albuterolhfa Spl Graphic 08)
Instructional illustration showing the correct mouthpiece-down position for holding the albuterol sulfate HFA aerosol inhaler. The image labels the mouthpiece and the cap, with a hand holding the inhaler in the proper orientation for use.*
FDA Label Image

Figure F (Albuterolhfa Spl Graphic 09)

Figure F (Albuterolhfa Spl Graphic 09)
An instructional illustration showing a side profile of a person's face with an arrow indicating to breathe out as much air as possible. The text reads, "Breathe out as much air as you can." This image appears to demonstrate part of the inhalation process for using an aerosol inhaler.*
FDA Label Image

Figure G (Albuterolhfa Spl Graphic 10)

Figure G (Albuterolhfa Spl Graphic 10)
An instructional illustration showing a person using an aerosol metered inhaler. The image demonstrates the action of pushing down on the inhaler while breathing in through the mouthpiece, with an arrow indicating inhalation direction.*
FDA Label Image

Figure H (Albuterolhfa Spl Graphic 11)

Figure H (Albuterolhfa Spl Graphic 11)
Illustration showing correct and incorrect usage of an inhaler. The top panel labeled 'Not blocked' shows proper inhaler spray with medication emitted freely, while the bottom panel labeled 'Blocked' depicts the inhaler sprayed against a surface blocking the medication flow.*
FDA Label Image

Figure I (Albuterolhfa Spl Graphic 12)

Figure I (Albuterolhfa Spl Graphic 12)
Instructional illustration showing a hand holding an albuterol sulfate HFA metered-dose inhaler under running water from a faucet, with water droplets splashing and the inhaler's cap removed. The image depicts cleaning or rinsing the inhaler device.*
FDA Label Image

Figure J (Albuterolhfa Spl Graphic 13)

Figure J (Albuterolhfa Spl Graphic 13)
An instructional illustration showing a hand holding an inhaler actuator under running water from a faucet, with a metered-dose inhaler canister next to it, demonstrating the cleaning process of an inhaler device.*
FDA Label Image

Albuterolhfa Spl Graphic 14

Albuterolhfa Spl Graphic 14
An instructional illustration showing an inhaler with its separate mouthpiece cover removed, placed lying down, and an image of a crescent moon, suggesting use at night or bedtime. The inhaler is likely related to albuterol sulfate HFA metered-dose aerosol inhalation.*
FDA Label Image

Label Image (Lbl500904137)

Label Image (Lbl500904137)
Albuterol sulfate HFA inhalation aerosol label showing the product number 6862-0 and strength 90 mcg per actuation. The label states 200 metered inhalations per container and provides storage conditions between 68 and 77 degrees Fahrenheit. It is distributed by A-S Medication Solutions, Libertyville, Illinois, and includes reference to dosage instructions on the package insert.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.